Identification of novel tumor markers in prostate, colon and breast cancer by unbiased methylation profiling.
DNA hypermethylation is a common epigenetic abnormality in cancer and may serve as a useful marker to clone cancer-related genes as well as a marker of clinical disease activity. To identify CpG islands methylated in prostate cancer, we used methylated CpG island amplification (MCA) coupled with rep...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2008-04-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC2323612?pdf=render |